• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发酵浆果饮料中的酚类化合物可调节基因和蛋白质表达,以增加体外胰腺β细胞的胰岛素分泌。

Phenolic Compounds from Fermented Berry Beverages Modulated Gene and Protein Expression To Increase Insulin Secretion from Pancreatic β-Cells in Vitro.

作者信息

Johnson Michelle H, de Mejia Elvira Gonzalez

机构信息

Division of Nutritional Sciences and ‡Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.

出版信息

J Agric Food Chem. 2016 Mar 30;64(12):2569-81. doi: 10.1021/acs.jafc.6b00239. Epub 2016 Mar 21.

DOI:10.1021/acs.jafc.6b00239
PMID:26967923
Abstract

Berries are a rich source of bioactive phenolic compounds that are able to bind and inhibit the enzyme dipeptidyl peptidase-IV (DPP-IV), a current target for type-2 diabetes therapy. The objectives were to determine the role of berry phenolic compounds to modulate incretin-cleaving DPP-IV and its substrate glucagon-like peptide-1 (GLP-1), insulin secretion from pancreatic β-cells, and genes and proteins involved in the insulin secretion pathway using cell culture. Anthocyanins (ANC) from 50% blueberry-50% blackberry (Blu-Bla) and 100% blackberry (Bla) fermented beverages at 50 μM cyanidin-3-glucoside equivalents increased (p < 0.05) glucose-stimulated insulin secretion from pancreatic β-cells (iNS-1E) both when applied directly and following simulated absorption through Caco-2 cells (by 233 and 100 μIU insulin/mL, respectively). ANC 50%Blu-Bla and ANC 100%Bla upregulated the gene for incretin hormone GLP-1 (fold-change 3.0 ± 1.4 and 2.0 ± 0.3, respectively) and genes in the insulin secretory pathway including insulin-like growth factor 1 receptor (iGF1R, 2.3 ± 0.6 and 1.6 ± 0.3, respectively), and increased (p < 0.05) the protein expression of insulin-like growth factor 2 (IGF-II), insulin-like growth factor binding proteins (IGFBP-2 and 3), and vascular endothelial growth factor (VEGF) in iNS-1E cells. Taken together, anthocyanins, predominantly delphinidin-3-arabinoside, from fermented berry beverages have the potential to modulate DPP-IV and its substrate GLP-1, to increase insulin secretion, and to upregulate expression of mRNA of insulin-receptor associated genes and proteins in pancreatic β-cells.

摘要

浆果富含生物活性酚类化合物,这些化合物能够结合并抑制二肽基肽酶-IV(DPP-IV),而DPP-IV是目前2型糖尿病治疗的靶点。本研究的目的是利用细胞培养来确定浆果酚类化合物在调节肠促胰岛素裂解DPP-IV及其底物胰高血糖素样肽-1(GLP-1)、胰腺β细胞胰岛素分泌以及胰岛素分泌途径中相关基因和蛋白质方面的作用。来自50%蓝莓-50%黑莓(蓝-黑)和100%黑莓(黑)发酵饮料中的花色苷(ANC),以50 μM矢车菊素-3-葡萄糖苷当量直接应用或经Caco-2细胞模拟吸收后,均增加了(p < 0.05)胰腺β细胞(iNS-1E)的葡萄糖刺激胰岛素分泌(分别为233和100 μIU胰岛素/mL)。50%蓝-黑ANC和100%黑ANC上调了肠促胰岛素激素GLP-1的基因(分别为3.0±1.4倍和2.0±0.3倍)以及胰岛素分泌途径中的基因,包括胰岛素样生长因子1受体(iGF1R,分别为2.3±0.6和1.6±0.3),并增加了(p < 0.05)iNS-1E细胞中胰岛素样生长因子2(IGF-II)、胰岛素样生长因子结合蛋白(IGFBP-2和3)以及血管内皮生长因子(VEGF)的蛋白表达。综上所述,来自发酵浆果饮料的花色苷,主要是飞燕草素-3-阿拉伯糖苷,有可能调节DPP-IV及其底物GLP-1,增加胰岛素分泌,并上调胰腺β细胞中胰岛素受体相关基因和蛋白质的mRNA表达。

相似文献

1
Phenolic Compounds from Fermented Berry Beverages Modulated Gene and Protein Expression To Increase Insulin Secretion from Pancreatic β-Cells in Vitro.发酵浆果饮料中的酚类化合物可调节基因和蛋白质表达,以增加体外胰腺β细胞的胰岛素分泌。
J Agric Food Chem. 2016 Mar 30;64(12):2569-81. doi: 10.1021/acs.jafc.6b00239. Epub 2016 Mar 21.
2
Anthocyanins and proanthocyanidins from blueberry-blackberry fermented beverages inhibit markers of inflammation in macrophages and carbohydrate-utilizing enzymes in vitro.蓝莓黑莓发酵饮料中的花色苷和原花青素体外抑制巨噬细胞炎症标志物和碳水化合物利用酶。
Mol Nutr Food Res. 2013 Jul;57(7):1182-97. doi: 10.1002/mnfr.201200678. Epub 2013 Mar 25.
3
Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.胰高血糖素样肽-1对胰岛β细胞的抗糖尿病作用。
Metabolism. 2014 Jan;63(1):9-19. doi: 10.1016/j.metabol.2013.09.010. Epub 2013 Oct 17.
4
Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.西他列汀和 Roux-en-Y 胃旁路手术通过调节胰岛内 PYY 来调节胰岛素分泌。
Diabetes Obes Metab. 2018 Mar;20(3):571-581. doi: 10.1111/dom.13113. Epub 2017 Oct 10.
5
Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.长期抑制二肽基肽酶-IV对高脂饮食喂养小鼠身体组成和葡萄糖耐量的影响。
Life Sci. 2009 Jun 19;84(25-26):876-81. doi: 10.1016/j.lfs.2009.03.022. Epub 2009 Apr 7.
6
The nonglycemic actions of dipeptidyl peptidase-4 inhibitors.二肽基肽酶-4抑制剂的非血糖作用。
Biomed Res Int. 2014;2014:368703. doi: 10.1155/2014/368703. Epub 2014 Jul 21.
7
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂的化学差异(结构)、作用机制及药理学
J Am Pharm Assoc (2003). 2009 Sep-Oct;49 Suppl 1:S16-29. doi: 10.1331/JAPhA.2009.09078.
8
Dipeptidyl peptidase IV inhibition activates CREB and improves islet vascularization through VEGF-A/VEGFR-2 signaling pathway.二肽基肽酶 IV 抑制通过 VEGF-A/VEGFR-2 信号通路激活 CREB 并改善胰岛血管生成。
PLoS One. 2013 Dec 11;8(12):e82639. doi: 10.1371/journal.pone.0082639. eCollection 2013.
9
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.抗糖尿病药物对二肽基肽酶IV活性的影响:那格列奈是二肽基肽酶IV的抑制剂,可增强胰高血糖素样肽-1的抗糖尿病活性。
Eur J Pharmacol. 2007 Jul 30;568(1-3):278-86. doi: 10.1016/j.ejphar.2007.05.010. Epub 2007 May 13.
10
The entero-insular axis: implications for human metabolism.肠-胰岛轴:对人体新陈代谢的影响。
Clin Chem Lab Med. 2008;46(1):43-56. doi: 10.1515/CCLM.2008.008.

引用本文的文献

1
's diabetes secrets: A comprehensive review of cellular, molecular, and epigenetic targets with immune modulation and microbiome influence.糖尿病的奥秘:对细胞、分子和表观遗传靶点以及免疫调节和微生物组影响的全面综述。
J Pharm Anal. 2025 May;15(5):101130. doi: 10.1016/j.jpha.2024.101130. Epub 2024 Oct 28.
2
Natural and Synthetic Flavylium Derivatives: Isolation/Synthesis, Characterization and Application.天然和合成的黄酮鎓衍生物:分离/合成、表征及应用
Molecules. 2024 Dec 29;30(1):90. doi: 10.3390/molecules30010090.
3
Dietary Polyphenols as Potential Therapeutic Agents in Type 2 Diabetes Management: Advances and Opportunities.
膳食多酚作为2型糖尿病管理中的潜在治疗剂:进展与机遇
Adv Nutr. 2025 Jan;16(1):100346. doi: 10.1016/j.advnut.2024.100346. Epub 2024 Nov 19.
4
Probing the Therapeutic Efficacy of Extract and GC-FID-Identified Phytochemicals as Novel Agents for Diabetes Mellitus.探究提取物及气相色谱-火焰离子化检测器鉴定的植物化学物质作为糖尿病新型治疗药物的疗效
Bioinform Biol Insights. 2024 Aug 23;18:11779322241271537. doi: 10.1177/11779322241271537. eCollection 2024.
5
The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated Complications.膳食花青素在管理糖尿病相关并发症中的作用。
Curr Diabetes Rev. 2025;21(9):e15733998322754. doi: 10.2174/0115733998322754240802063730.
6
Anthocyanins: Potential Therapeutic Approaches towards Obesity and Diabetes Mellitus Type 2.花色苷:肥胖症和 2 型糖尿病的潜在治疗方法。
Molecules. 2023 Jan 27;28(3):1237. doi: 10.3390/molecules28031237.
7
Hypoglycemic and Antioxidant Properties of Extracts and Fractions from Polygoni Avicularis Herba.鸡矢藤提取物和馏分的降血糖和抗氧化特性。
Molecules. 2022 May 24;27(11):3381. doi: 10.3390/molecules27113381.
8
Cherries and Blueberries-Based Beverages: Functional Foods with Antidiabetic and Immune Booster Properties.基于樱桃和蓝莓的饮料:具有降血糖和增强免疫力功能的功能性食品。
Molecules. 2022 May 20;27(10):3294. doi: 10.3390/molecules27103294.
9
Blueberry as an Attractive Functional Fruit to Prevent (Pre)Diabetes Progression.蓝莓作为一种极具吸引力的功能性水果,可预防(前期)糖尿病进展。
Antioxidants (Basel). 2021 Jul 22;10(8):1162. doi: 10.3390/antiox10081162.
10
Potential Application of Cornelian Cherry Extract on Broiler Chickens: Growth, Expression of Antioxidant Biomarker and Glucose Transport Genes, and Oxidative Stability of Frozen Meat.山茱萸提取物在肉鸡上的潜在应用:生长性能、抗氧化生物标志物和葡萄糖转运基因的表达以及冻肉的氧化稳定性
Animals (Basel). 2021 Apr 7;11(4):1038. doi: 10.3390/ani11041038.